Publications by authors named "Jon Durkin"


Phase I trial of AEG35156 administered as a 7-day and 3-day continuous intravenous infusion in patients with advanced refractory cancer.

J Clin Oncol 2009 Apr 23;27(10):1660-6. Epub 2009 Feb 23.

Christie Hospital National Health Service Foundation Trust, Clinical and Experimental Pharmacology, Paterson Institute for Cancer Research, and School of Pharmacy and Pharmaceutical Sciences, University of Manchester, Manchester, UK.

View Article and Find Full Text PDF
April 2009

Cytoprotective effects of IAPs revealed by a small molecule antagonist.

Biochem J 2009 Feb;417(3):765-71

Department of Pathology, University of Michigan, 1301 Catherine, 5240 Medical Science I, Ann Arbor, MI 48109, USA.

View Article and Find Full Text PDF
February 2009

Downregulation of XIAP expression in ovarian cancer cells induces cell death in vitro and in vivo.

Int J Cancer 2008 Mar;122(6):1430-4

Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario, Canada.

View Article and Find Full Text PDF
March 2008

Longitudinal evaluation of memory performance and peripheral neuropathy in the Ins2C96Y Akita mice.

Behav Brain Res 2005 Feb;157(1):31-8

School of Psychology, University of Ottawa, 11 Marie Curie, Room 215, Ottawa, Ont., Canada KIN 6N5.

View Article and Find Full Text PDF
February 2005